Gilles Dadaglio

Gilles Dadaglio

Auto-generated profile, based on publicly available information

Gilles Dadaglio

Immunobiology and Therapy Unit, Institut Pasteur, Université Paris Cité, Institut National de la Santé et de la Recherche Médicale (INSERM) U1224, Paris, France

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Blood
Verified
Journal Article
Open access
PDF file
JMJuliette Mouriès
Juliette Mouriès
GMGabriel Moron
Gabriel Moron
Géraldine SCHLECHT-LOUFGéraldine SCHLECHT-LOUF
Géraldine SCHLECHT-LOUF
NENicolas Escriou
Nicolas Escriou
GDGilles Dadaglio
Gilles Dadaglio
CLClaude Leclerc
Claude Leclerc
Cross-presentation is a crucial mechanism in tumoral and microbial immunity because it allows internalized cell associated or exogenous antigens (Ags) to be delivered into the major histocompatibility complex I pathway. This pathway is important for the development of CD8+ T-cell responses and for the induction of tolerance. In mice, cross-presentation is considered to be a unique property of CD8α+ conventional dendritic cells (DCs). Here we show that splenic plasmacytoid DCs (pDCs) efficiently capture exogenous Ags in vivo but are not able to cross-present these Ags at steady state. However, in vitro and in vivo stimulation by Toll-like receptor-7, or -9 or viruses licenses pDCs to cross-present soluble or particulate Ags by a transporter associated with antigen processing-dependent mechanism. Induction of cross-presentation confers to pDCs the ability to generate efficient effector CD8+ T-cell responses against exogenous Ags in vivo, showing that pDCs may play a crucial role in induction of adaptive immune responses against pathogens that do not infect tissues of hemopoietic origin. This study provides the first evidence for an in vivo role of splenic pDCs in Ag cross-presentation and T-cell cross-priming and suggests that pDCs may constitute an attractive target to boost the efficacy of vaccines based on cytotoxic T lymphocyte induction.

8 June 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
MOMarine Oberkampf
Marine Oberkampf
CGCamille Guillerey
Camille Guillerey
JMJuliette Mouriès
Juliette Mouriès
PRPierre Rosenbaum
Pierre Rosenbaum
CFCatherine Fayolle
Catherine Fayolle
GDGilles Dadaglio
Gilles Dadaglio
Cross-presentation allows exogenous antigen presentation in association with major histocompatibility complex class I molecules, a process crucial for the priming of CD8+ T-cell responses against viruses and tumors. By contrast to conventional dendritic cells (cDC), which cross-present antigens in the steady state, plasmacytoid dendritic cells (pDC) acquire this ability only after stimulation by Toll-like receptor (TLR) ligands. The intracellular pathways accounting for this functional difference are still unknown. Here we show that the induction of cross-presentation by pDCs is regulated by mitochondria through a reactive oxygen species (ROS)-dependent mechanism, involving pH alkalization and antigen protection. The reduction of mitochondrial ROS production dramatically decreases the cross-presentation capacity of pDCs, leading to a strong reduction of their capacity to trigger CD8+ T-cell responses. Our results demonstrate the importance of mitochondrial metabolism in pDC biology, particularly for the induction of adaptive immune responses.

1 June 1997 in Immunity
Verified
Journal Article
Closed access
GDGilles Dadaglio
Gilles Dadaglio
CNChristopher A Nelson
Christopher A Nelson
MDM.BRian Deck
M.BRian Deck
SPShirley J Petzold
Shirley J Petzold
EUEmil R Unanue
Emil R Unanue

15 September 2004 in Blood
Verified
Journal Article
Closed access
PDF file
Géraldine SCHLECHT-LOUFGéraldine SCHLECHT-LOUF
Géraldine SCHLECHT-LOUF
SGSylvie Garcia
Sylvie Garcia
NENicolas Escriou
Nicolas Escriou
AFAntonio A. Freitas
Antonio A. Freitas
CLClaude Leclerc
Claude Leclerc
GDGilles Dadaglio
Gilles Dadaglio
Like their human counterparts, mouse plasmacytoid dendritic cells (pDCs) play a central role in innate immunity against viral infections, but their capacity to prime T cells in vivo remains unknown. We show here that virus-activated pDCs differentiate into antigen-presenting cells able to induce effector/memory CD8+ T-cell responses in vivo against both epitopic peptides and endogenous antigen, whereas pDCs activated by synthetic oligodeoxynucleotides containing unmethylated cytosine-guanine motifs (CpG) acquire only the ability to recall antigen-experienced T-cell responses. We also show that immature pDCs are unable to induce effector or regulatory CD8+ T-cell responses. Thus, murine pDCs take part in both innate and adaptive immune responses by directly priming naive CD8+ T cells during viral infection.

1 February 2004 in Trends in Immunology
Verified
Journal Article
Closed access
GMGabriel Morón
Gabriel Morón
GDGilles Dadaglio
Gilles Dadaglio
CLClaude Leclerc
Claude Leclerc

1 July 2000 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
CSC. Sedlik
C. Sedlik
GDG. Dadaglio
G. Dadaglio
MSM. F. Saron
M. F. Saron
EDE. Deriaud
E. Deriaud
MRM. Rojas
M. Rojas
CLC. Leclerc
C. Leclerc
Many approaches are currently being developed to deliver exogenous antigen into the major histocompatibility complex class I-restricted antigen pathway, leading to in vivo priming of CD8+cytotoxic T cells. One attractive possibility consists of targeting the antigen to phagocytic or macropinocytic antigen-presenting cells. In this study, we demonstrate that strong CD8+class I-restricted cytotoxic responses are induced upon intraperitoneal immunization of mice with different peptides, characterized as CD8+T-cell epitopes, bound to 1-μm synthetic latex microspheres and injected in the absence of adjuvant. The cytotoxic response induced against a lymphocytic choriomeningitis virus (LCMV) peptide linked to these microspheres was compared to the cytotoxic T-lymphocyte (CTL) response obtained upon immunization with the nonreplicative porcine parvovirus-like particles (PPV:VLP) carrying the same peptide (PPV:VLP-LCMV) previously described (C. Sedlik, M. F. Saron, J. Sarraseca, I. Casal, and C. Leclerc, Proc. Natl. Acad. Sci. USA 94:7503–7508, 1997). We show that the induction of specific CTL activity by peptides bound to microspheres requires CD4+T-cell help in contrast to the CTL response obtained with the peptide delivered by viral pseudoparticles. Furthermore, PPV:VLP are 100-fold more efficient than microspheres in generating a strong CTL response characterized by a high frequency of specific T cells of high avidity. Moreover, PPV:VLP-LCMV are able to protect mice against a lethal LCMV challenge whereas microspheres carrying the LCMV epitope fail to confer such protection. This study demonstrates the crucial involvement of the frequency and avidity of CTLs in conferring antiviral protective immunity and highlights the importance of considering these parameters when developing new vaccine strategies.